Serum Fibroblast Growth Factor 23 Level and Liver Fat Content in MAFLD: A Community-Based Cohort
Weijie Cao,* Yiting Xu,* Yun Shen, Yufei Wang, Xiaojing Ma, Yuqian Bao Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital; Shanghai Clinical Center for Diabetes; Shanghai Key Clinical Center for Metabolic Disease; Shanghai Dia...
Main Authors: | Cao W, Xu Y, Shen Y, Wang Y, Ma X, Bao Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-fibroblast-growth-factor-23-level-and-liver-fat-content-in-mafld-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD
by: Ting Zhou, et al.
Published: (2023-12-01) -
Correlation between serum uric acid and body fat distribution in patients with MAFLD
by: Min Tao, et al.
Published: (2023-09-01) -
MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
by: Huang J, et al.
Published: (2021-02-01) -
Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
by: Tingfeng Wu, et al.
Published: (2021-11-01) -
Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity
by: Katharina Mörwald, et al.
Published: (2020-06-01)